Guobang Pharma Ltd (605507) — Cash Flow Reinvestment Rate
Guobang Pharma Ltd (605507) has a Cash Flow Reinvestment Rate of 0.36x as of September 2025, reinvesting CN¥110.58 Million (capex CN¥110.58 Million ) from operating cash flow of CN¥311.27 Million. Explore 605507 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Guobang Pharma Ltd Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for Guobang Pharma Ltd across 8 annual periods. Also explore Guobang Pharma Ltd balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Guobang Pharma Ltd (2017–2025)
Year-by-year capital reinvestment analysis for Guobang Pharma Ltd. For live market cap and broader valuation context, see Guobang Pharma Ltd stock valuation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.57x | CN¥875.56 Million | CN¥559.28 Million | CN¥277.71 Million | ▲ +108.0% |
| 2024 | 0.75x | CN¥531.80 Million | CN¥706.41 Million | CN¥419.12 Million | ▼ -64.9% |
| 2023 | 2.15x | CN¥1.11 Billion | CN¥516.76 Million | CN¥748.44 Million | ▲ +79.8% |
| 2022 | 1.19x | CN¥1.21 Billion | CN¥1.02 Billion | CN¥803.12 Million | ▲ +3.6% |
| 2020 | 1.15x | CN¥885.39 Million | CN¥767.70 Million | CN¥520.16 Million | ▼ -44.3% |
| 2019 | 2.07x | CN¥912.52 Million | CN¥440.86 Million | CN¥605.18 Million | ▲ +586.8% |
| 2018 | 0.30x | CN¥163.24 Million | CN¥541.68 Million | CN¥163.24 Million | ▼ -73.7% |
| 2017 | 1.14x | CN¥169.48 Million | CN¥148.03 Million | CN¥169.48 Million | — |